for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Ascendis Health Ltd

ASCJ.J

Latest Trade

311.00ZAc

Change

21.00(+7.24%)

Volume

53,086

Today's Range

295.00

 - 

311.00

52 Week Range

290.00

 - 

653.00

As of on the Johannesburg Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Ascendis Health Says Gane Holdings Proprietary's Interest In Co Is 4.89%

Nov 8 (Reuters) - Ascendis Health Ltd <ASCJ.J>::DISCLOSURE OF BENEFICIAL INTERESTS.GANE HOLDINGS PROPRIETARY'S BENEFICIAL INTEREST IN ASCENDIS HEALTH NOW AMOUNTS TO 4.89% OF TOTAL NUMBER OF ORDINARY SHARES IN ISSUE.INTERNATIONAL FINANCE CORPORATION'S BENEFICIAL INTEREST IN CO AMOUNTS TO 12.6% OF TOTAL NUMBER OF ORDINARY SHARES IN ISSUE.

Ascendis Health Reports FY Headline Loss Per Share Of 39.6 Cents

Oct 30 (Reuters) - Ascendis Health Ltd <ASCJ.J>::JSE: ASC - AUDITED ABRIDGED FINANCIAL RESULTS FOR THE YEAR ENDED 30 JUNE 2019.ASCENDIS HEALTH LTD - FY REVENUE UP 1% TO R5.6 BILLION.ASCENDIS HEALTH LTD - FY IMPAIRMENT CHARGE OF R4.2 BILLION.ASCENDIS HEALTH LTD - NO DIVIDENDS WERE DECLARED OR PAID DURING YEAR UNDER REVIEW OR DURING PREVIOUS FINANCIAL YEAR..ASCENDIS HEALTH LTD - FY HEADLINE LOSS PER SHARE WAS 39.6 CPS.ASCENDIS HEALTH - ENTERED INTO AN EXCLUSIVITY AGREEMENT WITH PREFERRED BIDDER IN RESPECT OF DISPOSAL OF REMEDICA BUSINESS IN CYPRUS.ASCENDIS HEALTH - NEGOTIATIONS OF DISPOSAL OF REMEDICA BUSINESS IN CYPRUS ARE AT AN ADVANCED STAGE.

Ascendis Says FY Results Impacted By "Adverse" Trading Conditions In South African Consumer Markets

Oct 22 (Reuters) - Ascendis Health Ltd <ASCJ.J>::TRADING STATEMENT FOR THE YEAR ENDED 30 JUNE 2019 AND RENEWAL OF CAUTIONARY ANNOUNCEMENT.IN FY GROUP INCURRED CONSULTING AND PROFESSIONAL FEES ASSOCIATED WITH RESTRUCTURING OF SENIOR LENDER DEBT, AND OTHER ONCE-OFF COSTS.FY RESULTS ENDED JUNE 30 IMPACTED BY ADVERSE TRADING CONDITIONS IN SOUTH AFRICAN CONSUMER MARKET, EUROPEAN SPORTS NUTRITION BUSINESS.IN FY, LOWER SALES IN SOUTH AFRICA CAUSED BY LIQUIDITY CONSTRAINTS AND RELATED SUPPLY CHALLENGES, DEPRESSED CONSUMER ENVIRONMENT.FY EPS FROM CONTINUING OPERATIONS ADJUSTED FOR ONCE-OFF COSTS OF ABOUT R120 MILLION.IN FY RESTRUCTURING OF GROUP DEBT, INCLUDING COSTS OF PROPOSED CORPORATE BOND ISSUE THAT WAS NOT LAUNCHED R81 MILLION.PRIOR YEAR ERRORS RESULTED IN RESTATEMENT OF EPS AND HEPS ATTRIBUTABLE TO TOTAL OPERATIONS.PRIOR YEAR ERRORS HAS RESULTED IN A REDUCTION IN EARNINGS OF R20 MILLION.RESTATEMENT DUE TO PRIOR YEAR ERRORS RESULTED IN DECREASE IN BASIC AND DILUTED EPS OF 4.1 CENTS PER SHARE.

Ascendis Health Says In Negotiations Over Potential Disposal Of Remedica

Sept 3 (Reuters) - Ascendis Health Ltd <ASCJ.J>::IN ONGOING NEGOTIATIONS REGARDING POTENTIAL DISPOSAL OF REMEDICA.

Ascendis Health Appoints Mark Sardi As CEO

Sept 2 (Reuters) - Ascendis Health Ltd <ASCJ.J>::APPOINTMENT OF CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR.APPOINTMENT OF MARK SARDI AS CHIEF EXECUTIVE OFFICER.APPOINTMENT OF MARK SARDI AS CEO AND N EXECUTIVE DIRECTOR WITH EFFECT FROM 14 OCTOBER.

Ascendis Health Says Disposal Of Businesses Within Biosciences Division Unconditional

July 31 (Reuters) - Ascendis Health Ltd <ASCJ.J>::DISPOSAL OF BUSINESSES WITHIN THE ASCENDIS HEALTH BIOSCIENCES DIVISION: TRANSACTION UNCONDITIONAL.ALL CONDITIONS PRECEDENT TO DIVESTING BUSINESSES IN BIOSCIENCES UNIT HAVE BEEN FULFILLED AND DEAL HAS BECOME UNCONDITIONAL.AVIMA PROPRIETARY LIMITED AND KLUB M5 PROPRIETARY LIMITED, ARE NOW BEING CONSIDERED FOR DIVESTMENT.

Ascendis Health Says Still Negotiating Potential Disposal Of Remedica

July 22 (Reuters) - Ascendis Health Ltd <ASCJ.J>::FURTHER CAUTIONARY ANNOUNCEMENT.INVOLVED IN NEGOTIATIONS REGARDING POTENTIAL DISPOSAL OF REMEDICA AND WILL UPDATE INVESTORS SHOULD A DEAL BE CONCLUDED.

Ascendis Health Says Thomas Thomsen Steps Down As CEO

May 23 (Reuters) - Ascendis Health Ltd <ASCJ.J>::ASCENDIS HEALTH LTD - EMPLOYMENT CONTRACT OF THOMAS THOMSEN, CHIEF EXECUTIVE OFFICER OF ASCENDIS HEALTH, HAS BEEN TERMINATED WITH IMMEDIATE EFFECT.ASCENDIS HEALTH LTD - ANDREW MARSHALL, BOARD'S CURRENT CHAIRMAN, WILL BE ACTING AS CEO UNTIL BOARD HAS APPOINTED A SUITABLE REPLACEMENT FOR THOMSEN.

Ascendis Health Says John A Bester Has Retired From Board As Chairman

May 3 (Reuters) - Ascendis Health Ltd <ASCJ.J>::ASCENDIS HEALTH LTD - JOHN A BESTER HAS RETIRED FROM BOARD AS CHAIRMAN.ASCENDIS HEALTH LTD - ANDREW B MARSHALL HAS BEEN APPOINTED TO BOARD AS CHAIRMAN.

Ascendis Health Announces Disposal Of Afrikelp, Efekto And Marltons Businesses Within The Co's Biosciences Division

May 2 (Reuters) - Ascendis Health Ltd <ASCJ.J>::JSE: ASC - DISPOSAL OF AFRIKELP, EFEKTO AND MARLTONS BUSINESSES WITHIN THE ASCENDIS BIOSCIENCES DIVISION.ASCENDIS HEALTH LTD - TOTAL CONSIDERATION PAYABLE TO CO FOR DISPOSAL BUSINESSES IS A BASE PRICE OF R480 MILLION.ASCENDIS HEALTH - GOT INTO AGREEMENTS WITH CONSORTIUM OF RMB VENTURES SEVEN PROPRIETARY, NEDBANK PRIVATE EQUITY.ASCENDIS HEALTH - AVIMA PROPRIETARY LIMITED AND KLUB M5 PROPRIETARY LIMITED MAY BE CONSIDERED FOR DIVESTMENT IN SHORT TO MEDIUM TERM.ASCENDIS HEALTH LTD - ASCENDIS BIOSCIENCES DIVISION WILL BE RESTRUCTURED AND DISPOSED OF TRANSACTION.ASCENDIS HEALTH - CASH PROCEEDS FROM TRANSACTION WILL BE APPLIED TO REDUCE DEBT LEVELS AND FUND WORKING CAPITAL.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up